Case Studies

Craig I. Coleman, PharmD, and Christine G. Kohn PharmD Candidate
Published Online: Monday, July 11, 2011
Follow Pharmacy_Times:

Case One

MK, a 68-year-old man, was discharged from the hospital after a myocardial infarction (MI) 2 weeks ago. At this routine office visit, MK is diagnosed with depression. His doctor considers prescribing a tricyclic antidepressant (TCA), but contacts his community pharmacist for a recommendation.

What should the pharmacist recommend to manage MK's post-MI depression?

Case Two

SL, a 25-year-old woman, presents to the clinic complaining of an increased frequency and urgency to urinate and dysuria over the past 3 days. She has no fever or flank pain and does not have a recent history of urinary tract infections (UTIs). A urine dipstick is positive for leukocyte esterase, white blood cells, and nitrates. Based upon the above symptoms and test results, and the fact that SL has no known urologic abnormalities, her doctor diagnoses her with an uncomplicated UTI. SL's doctor considers prescribing a fluoroquinolone, but asks you, the pharmacist, for a recommendation. SL has no known drug allergies.

How should the pharmacist handle this prescription?




Dr. Coleman is associate professor of pharmacy practice and director of the pharmacoeconomics and outcomes studies group at the University of Connecticut School of Pharmacy.  Ms. Kohn is a PharmD candidate from the University of Connecticut School of Pharmacy. 

Related Articles
Taking another step toward preventing and treating inflammatory bowel disease (IBD), an international team of investigators has determined that the gut bacteria behind Crohn’s disease and ulcerative colitis may be inherited, and antibiotics can make those patients’ gut imbalance worse.
Merck announced a definitive agreement to acquire Cubist Pharmaceuticals, a biopharmaceutical company focused on superbugs.
Bayer is expanding its aid donations for Ebola patients in Liberia and Sierra Leone.
Children exposed to antibiotics during the second or third trimester of pregnancy have an 84% higher risk of being obese at age 7 compared with children who were not exposed to the drugs in utero, according to new research published in the Journal of Obesity.
Latest Issues